SOURCE: ThinkEquity Partners

November 30, 2006 15:27 ET

ThinkEquity Partners LLC Announced Today That Kenneth I. Moch Has Joined Its Healthcare Investment Banking Team

SAN FRANCISCO, CA -- (MARKET WIRE) -- November 30, 2006 -- ThinkEquity Partners LLC announced today that Kenneth I. Moch has joined the Healthcare Investment Banking Team.

Mr. Moch's work experience includes serving as Chairman, President and CEO of Alteon Inc., President & CEO of Biocyte Corporation, the Managing General Partner of Catalyst Ventures, L.P., and a Co-founder and Vice President of The Liposome Company. Mr. Moch is currently the Chairman of the Biotechnology Council of New Jersey (BCNJ) and a member of Board of the Emerging Companies Section of the Biotechnology Industry Organization (BIO). He previously served as Co-Chair of the Executive Committee of the BIO 2005, BIO's annual international meeting, and a member of the Executive Committee of the New York Biotechnology Association (NYBA).

In announcing the appointment, Deborah Quazzo, ThinkEquity's President and Head of Investment Banking, said, "The addition of Ken Moch to our Banking team continues to broaden the depth of our fast-growing organization. His knowledge of the healthcare industry will add significantly to our firm's reputation as being on the cutting edge of biotech banking."

Mr. Moch holds a degree in Biochemistry from of Princeton University and an MBA from the Stanford Graduate School of Business, and will work in the New York City office.

About ThinkEquity Partners LLC

ThinkEquity Partners LLC is a research-centric institutional investment firm focused on the growth economy. ThinkEquity Partners LLC is dedicated to providing focused insight, advisory services, and capital to institutional investors and corporate constituents in the knowledge economy's key growth verticals, including technology, healthcare, media, and consumer business services. For more information about ThinkEquity Partners LLC, please visit Member NASD and SIPC.

Contact Information